Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

914 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Synthesis and structure-activity relationships of oxamyl dipeptide caspase inhibitors developed for the treatment of liver disease.
Ueno H, Kawai M, Shimokawa H, Hirota M, Ohmi M, Sudo R, Ohta A, Arano Y, Hattori K, Ohmi T, Kato N, Kojima M, Ueno Y, Yamamoto M, Moriguchi Y, Eda H, Masubuchi K. Ueno H, et al. Among authors: ohta a. Bioorg Med Chem Lett. 2009 Jan 1;19(1):199-202. doi: 10.1016/j.bmcl.2008.10.117. Epub 2008 Nov 5. Bioorg Med Chem Lett. 2009. PMID: 19013793
Discovery of novel and orally active NR2B-selective N-methyl-D-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity.
Kawai M, Nakamura H, Sakurada I, Shimokawa H, Tanaka H, Matsumizu M, Ando K, Hattori K, Ohta A, Nukui S, Omura A, Kawamura M. Kawai M, et al. Among authors: ohta a. Bioorg Med Chem Lett. 2007 Oct 15;17(20):5533-6. doi: 10.1016/j.bmcl.2007.08.039. Epub 2007 Aug 22. Bioorg Med Chem Lett. 2007. PMID: 17768047
Discovery of (-)-6-[2-[4-(3-fluorophenyl)-4-hydroxy-1-piperidinyl]-1-hydroxyethyl]-3,4-dihydro-2(1H)-quinolinone--a potent NR2B-selective N-methyl D-aspartate (NMDA) antagonist for the treatment of pain.
Kawai M, Ando K, Matsumoto Y, Sakurada I, Hirota M, Nakamura H, Ohta A, Sudo M, Hattori K, Takashima T, Hizue M, Watanabe S, Fujita I, Mizutani M, Kawamura M. Kawai M, et al. Among authors: ohta a. Bioorg Med Chem Lett. 2007 Oct 15;17(20):5558-62. doi: 10.1016/j.bmcl.2007.08.014. Epub 2007 Aug 15. Bioorg Med Chem Lett. 2007. PMID: 17766106
Synthesis of benzamide derivatives as TRPV1 antagonists.
Shishido Y, Jinno M, Ikeda T, Ito F, Sudo M, Makita N, Ohta A, Iki-Taki A, Ohmi T, Kanai Y, Tamura T, Shimojo M. Shishido Y, et al. Among authors: ohta a. Bioorg Med Chem Lett. 2008 Feb 1;18(3):1072-8. doi: 10.1016/j.bmcl.2007.12.007. Epub 2007 Dec 10. Bioorg Med Chem Lett. 2008. PMID: 18155908
The SAR studies of novel CB2 selective agonists, benzimidazolone derivatives.
Omura H, Kawai M, Shima A, Iwata Y, Ito F, Masuda T, Ohta A, Makita N, Omoto K, Sugimoto H, Kikuchi A, Iwata H, Ando K. Omura H, et al. Among authors: ohta a. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3310-4. doi: 10.1016/j.bmcl.2008.04.032. Epub 2008 Apr 15. Bioorg Med Chem Lett. 2008. PMID: 18440813
Discovery of small-molecule nonpeptide antagonists of nociceptin/orphanin FQ receptor: The studies of design, synthesis, and structure-activity relationships for (4-arylpiperidine substituted-methyl)-[bicyclic (hetero)cycloalkanobenzene] derivatives.
Hayashi S, Ohashi K, Mihara S, Nakata E, Emoto C, Ohta A. Hayashi S, et al. Among authors: ohta a. Eur J Med Chem. 2016 May 23;114:345-64. doi: 10.1016/j.ejmech.2016.02.014. Epub 2016 Feb 6. Eur J Med Chem. 2016. PMID: 27043173
914 results